Suppr超能文献

非转移性肾细胞癌根治性手术后复发的临床病理特征。

Clinicopathological features of recurrence after radical surgery for nonmetastatic renal cell carcinoma.

作者信息

Ishimura Takeshi, Sakai Iori, Harada Ken-Ichi, Hara Isao, Eto Hiroshi, Miyake Hideaki

机构信息

Department of Urology, Hyogo Medical Center for Adults, 13-70 Kitaohji-cho, Akashi 673-8558, Japan.

出版信息

Int J Clin Oncol. 2004 Oct;9(5):369-72. doi: 10.1007/s10147-004-0409-1.

Abstract

BACKGROUND

The objective of this study was to clarify the clinicopathological features of recurrent renal cell carcinoma (RCC) in patients who had undergone curative surgical resection of primary disease.

METHODS

The study included 171 patients treated by radical surgery for nonmetastatic RCC in our institution. Several clinicopathological factors were analyzed to determine differences between patients with and without disease recurrence. We further investigated predictive factors for disease recurrence, as well as prognostic factors after disease recurrence, using univariate and multivariate analyses.

RESULTS

Thirty-four of the 171 patients (19.9%) developed recurrence, and the median time from surgery to recurrence was 11 months (range, 1 to 146 months). The incidence of disease recurrence was significantly associated with sex, mode of detection, tumor size, pathological stage, tumor grade, and microvascular invasion (MVI). Univariate analysis showed that five factors--mode of detection, tumor size, pathological stage, tumor grade, and MVI--were found to be significant risk factors for recurrence after surgery, while only the pathological stage was an independent predictor of recurrence by multivariate analysis. After disease recurrence, the 1-, 3-, and 5-year cancer-specific survival rates were 66.3%, 45.9%, and 13.4%, respectively. Despite the absence of independent prognostic predictors after recurrence, recurrence more than 1 year after surgery and complete resection of recurrent lesions were shown to be significant prognostic factors by univariate analysis.

CONCLUSION

These findings suggest that careful follow-up should be performed for patients showing a high pathological stage after radical surgery for nonmetastatic RCC, because of the higher probability of disease recurrence, and that after recurrence, intensive treatment should be considered, particularly for patients with unresectable recurrent disease occurring within 1 year after initial radical surgery.

摘要

背景

本研究的目的是阐明接受原发性疾病根治性手术切除的复发性肾细胞癌(RCC)患者的临床病理特征。

方法

本研究纳入了在我们机构接受根治性手术治疗的171例非转移性RCC患者。分析了几个临床病理因素,以确定疾病复发患者和未复发患者之间的差异。我们进一步使用单因素和多因素分析研究疾病复发的预测因素以及疾病复发后的预后因素。

结果

171例患者中有34例(19.9%)出现复发,从手术到复发的中位时间为11个月(范围为1至146个月)。疾病复发的发生率与性别、检测方式、肿瘤大小、病理分期、肿瘤分级和微血管侵犯(MVI)显著相关。单因素分析显示,检测方式、肿瘤大小、病理分期、肿瘤分级和MVI这五个因素是术后复发的显著危险因素,而多因素分析显示只有病理分期是复发的独立预测因素。疾病复发后,1年、3年和5年的癌症特异性生存率分别为66.3%、45.9%和13.4%。尽管复发后没有独立的预后预测因素,但单因素分析显示,手术后1年以上复发以及复发病灶的完全切除是显著的预后因素。

结论

这些发现表明,对于非转移性RCC根治性手术后病理分期高的患者应进行密切随访,因为疾病复发的可能性更高,并且复发后应考虑强化治疗,特别是对于初次根治性手术后1年内出现不可切除复发病变的患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验